Home OncoCell MDx

OncoCell MDx

In operation
Series B
Non-invasive Blood Testing Product R&D and Manufacturer

Basic Information

OncoCell MDx is a pan-disease immunogenomics platform company developing novel non-invasive blood tests to optimize patient care, aiming to help doctors better understand the underlying disease pathology of prostate cancer and other conditions.
OncoCell MDx
Michigan,United States of America
15~50 people
--
--